Logo image of CGBS

CROWN LNG HOLDINGS LTD (CGBS) Stock Fundamental Analysis

NASDAQ:CGBS - Nasdaq - JE00BPSKDR41 - Common Stock - Currency: USD

0.148  0 (0%)

After market: 0.1431 0 (-3.31%)

Fundamental Rating

1

Taking everything into account, CGBS scores 1 out of 10 in our fundamental rating. CGBS was compared to 212 industry peers in the Oil, Gas & Consumable Fuels industry. CGBS has a bad profitability rating. Also its financial health evaluation is rather negative. CGBS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CGBS has reported negative net income.
CGBS had a negative operating cash flow in the past year.
CGBS Yearly Net Income VS EBIT VS OCF VS FCFCGBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2020 2021 2022 2023 0 -5M -10M -15M -20M -25M

1.2 Ratios

CGBS has a worse Return On Assets (-11.72%) than 86.79% of its industry peers.
The Return On Equity of CGBS (-13.36%) is worse than 77.83% of its industry peers.
Industry RankSector Rank
ROA -11.72%
ROE -13.36%
ROIC N/A
ROA(3y)-32.35%
ROA(5y)N/A
ROE(3y)-73.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CGBS Yearly ROA, ROE, ROICCGBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CGBS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CGBS Yearly Profit, Operating, Gross MarginsCGBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2020 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

CGBS has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, CGBS has an improved debt to assets ratio.
CGBS Yearly Shares OutstandingCGBS Yearly Shares OutstandingYearly Shares Outstanding 2015 2020 2021 2022 2023 10M 20M 30M 40M 50M
CGBS Yearly Total Debt VS Total AssetsCGBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

CGBS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CGBS (0.04) is better than 82.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CGBS Yearly LT Debt VS Equity VS FCFCGBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.22 indicates that CGBS may have some problems paying its short term obligations.
With a Current ratio value of 0.22, CGBS is not doing good in the industry: 93.87% of the companies in the same industry are doing better.
A Quick Ratio of 0.22 indicates that CGBS may have some problems paying its short term obligations.
With a Quick ratio value of 0.22, CGBS is not doing good in the industry: 91.98% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
CGBS Yearly Current Assets VS Current LiabilitesCGBS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2020 2021 2022 2023 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

CGBS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1355.56%.
EPS 1Y (TTM)-1355.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1503.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CGBS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CGBS Price Earnings VS Forward Price EarningsCGBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGBS Per share dataCGBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CGBS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CROWN LNG HOLDINGS LTD

NASDAQ:CGBS (4/17/2025, 8:08:10 PM)

After market: 0.1431 0 (-3.31%)

0.148

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.66%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap68.27M
AnalystsN/A
Price TargetN/A
Short Float %1.81%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.33
EV/EBITDA N/A
EPS(TTM)-1.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.45
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.72%
ROE -13.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-32.35%
ROA(5y)N/A
ROE(3y)-73.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z N/A
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1355.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1503.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-908.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-549.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-549.01%
OCF growth 3YN/A
OCF growth 5YN/A